Active Shortage Injection Oncology
Azacitidine Injection · 2,090 days since initial FDA posting
Brand: AZACITIDINE
FDA lists Azacitidine Injection as Active Shortage (Accord Healthcare Inc.).
Availability on file: Available
Azacitidine Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Azacitidine Injection
- Manufacturer
- Accord Healthcare Inc.
- Dosage Form
- Injection
- Presentation
- Azacitidine, Injection, 100 mg (NDC 16729-306-10)
- Package NDC
- 16729-306-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Dec 21, 2020
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Oncology
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Azacitidine Shortage Records
Azacitidine Injection
Meitheal Pharmaceuticals, Inc.
Injection
Azacitidine Injection
Eugia US LLC
Injection
Azacitidine Injection
Fresenius Kabi USA, LLC
Injection
Azacitidine Injection
Bristol Myers Squibb Co.
Injection
Azacitidine Injection
Dr. Reddy's Laboratories, Inc.
Injection
Azacitidine Injection
Teva Pharmaceuticals USA, Inc.
Injection